The first hint that CD8 T cells could play a key role in MS came from immunohistochemical studies assessing the frequency and distribution of different T cell subsets in postmortem brain specimens of patients dying during the chronic phase of MS (111–113). The gene discussed is CD8A; the disease is myeloid sarcoma.